MARKER THERAPEUTICS (MRKR)
(Delayed Data from NSDQ)
$5.40 USD
+0.56 (11.57%)
Updated Jul 24, 2024 03:59 PM ET
After-Market: $5.53 +0.13 (2.41%) 7:58 PM ET
4-Sell of 5 4
F Value F Growth A Momentum F VGM
Industry / Sector Report
Industry : Medical - Drugs
Zacks Industry Rank
Top 40% (100 out of 250)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.00 | 1.52 | 9.99 |
Current Quarter Estimate | NA | -2.04 | 61.00 |
Year Ago Quarter Estimate | -0.47 | -0.59 | 54.84 |
Next Quarter Estimate | NA | -2.00 | 63.00 |
Next Year Estimate | -1.33 | 6.92 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | -3.14 | 13.30 | 15.67 |
Next Year | 18.90 | 16.00 | 9.31 |
Last 5 Years | NA | 7.00 | 8.10 |
Next 5 Years | NA | 25.30 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -5.88 |
Price/Book (MRQ) | 3.66 | 1.82 |
Price/Cash Flow (MRFY) | NA | 8.53 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | NA | -315.56% |
Return on Equity (TTM) | NA | -82.03% |
Debt to Equity (MRQ) | NA | 0.04 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.